国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
International Medicine and Health Guidance News
2015年
20期
3038-3040
,共3页
阿托伐他汀%普罗布考%急性脑梗死%脂质代谢
阿託伐他汀%普囉佈攷%急性腦梗死%脂質代謝
아탁벌타정%보라포고%급성뇌경사%지질대사
Atorvastatin%Probucol%Acute cerebral infarction%Lipid metabolism
目的 探讨阿托伐他汀联合普罗布考对急性脑梗死患者脂质代谢的影响效果.方法 收集我院2012年4月至2015年1月收治的急性脑梗死患者80例前瞻性研究且随机分为两组,每组40人,对照组患者给予口服阿托伐他汀片,实验组患者在以上基础上加服普罗布考,比较两组患者治疗前后TC、TG、LDL-C与HDL-C水平变化.结果 对照组患者治疗后TC、TG、LDL-C与HDL-C水平与治疗前组内比较差异具有统计学意义(P<0.05);实验组患者治疗后TC、TG、LDL-C与HDL-C水平与治疗前组内比较差异具有统计学意义(P<0.01);两组患者治疗后TC、TG、LDL-C与HDL-C水平组间比较差异具有统计学意义(P<0.01).结论 阿托伐他汀联合普罗布考对急性脑梗死患者脂质代谢的影响效果显著,具有借鉴性.
目的 探討阿託伐他汀聯閤普囉佈攷對急性腦梗死患者脂質代謝的影響效果.方法 收集我院2012年4月至2015年1月收治的急性腦梗死患者80例前瞻性研究且隨機分為兩組,每組40人,對照組患者給予口服阿託伐他汀片,實驗組患者在以上基礎上加服普囉佈攷,比較兩組患者治療前後TC、TG、LDL-C與HDL-C水平變化.結果 對照組患者治療後TC、TG、LDL-C與HDL-C水平與治療前組內比較差異具有統計學意義(P<0.05);實驗組患者治療後TC、TG、LDL-C與HDL-C水平與治療前組內比較差異具有統計學意義(P<0.01);兩組患者治療後TC、TG、LDL-C與HDL-C水平組間比較差異具有統計學意義(P<0.01).結論 阿託伐他汀聯閤普囉佈攷對急性腦梗死患者脂質代謝的影響效果顯著,具有藉鑒性.
목적 탐토아탁벌타정연합보라포고대급성뇌경사환자지질대사적영향효과.방법 수집아원2012년4월지2015년1월수치적급성뇌경사환자80례전첨성연구차수궤분위량조,매조40인,대조조환자급여구복아탁벌타정편,실험조환자재이상기출상가복보라포고,비교량조환자치료전후TC、TG、LDL-C여HDL-C수평변화.결과 대조조환자치료후TC、TG、LDL-C여HDL-C수평여치료전조내비교차이구유통계학의의(P<0.05);실험조환자치료후TC、TG、LDL-C여HDL-C수평여치료전조내비교차이구유통계학의의(P<0.01);량조환자치료후TC、TG、LDL-C여HDL-C수평조간비교차이구유통계학의의(P<0.01).결론 아탁벌타정연합보라포고대급성뇌경사환자지질대사적영향효과현저,구유차감성.
Objective To investigate the effect of atorvastatin combined with probucol on lipid metabolism in patients with acute cerebral infarction (ACI).Methods 80 cases of ACI in our hospital from April 2012 to January 2015 were selected and randomly divided into two groups, 40 cases in each group.Patients in control group were given atorvastatin for oral administration, patients in experimental group were given probucol on the basis of control group.Compared the levels of TC, TG, LDL-C and HDL-C of two groups before and after treatment.Results There were statistically significant differences in the levels ofTC, TG, LDL-C and HDL-C before and after treatment in both two groups (P<0.05).There were statistically significant differences in the levels of TC, TG, LDL-C and HDL-C after treatment between two groups (P<0.01).Conclusion Atorvastatin combined with probucol has significant effect on lipid metabolism in patients with ACI, worthy of clinical application.